Big Pharma AstraZeneca is looking to hire an OV scientist In this role the candidate will join a team of in vitro and in vivo virologists/biologists in the Oncolytic Virotherapy group to support oncolytic virus (OV) programs in AstraZeneca’s Early Discovery portfolio .
Desired for the role are:
Recognized contributor in oncolytic virology; experience within the pharmaceutical/biotech industry and the drug discovery process and/or academic experience with viruses as therapeutics (oncolytic viruses, viruses as vectors or vaccine platforms); hands on experience in mining and interpretation of biological datasets such as RNAseq, TCGA, or other open-source or in-house genomic datasets; and experience in immunology and immuno-oncology, including the combination of oncolytic virotherapy with immunotherapies or other standard-of-care therapies.
https://careers.astrazeneca.com/job/gaithersburg/senior-scientist-in-oncolytic-virotherapy-tumor-targeted-delivery-oncology-r-and-d/7684/33353714112
[ So this demonstrates that Big Pharma's interest in oncolytic virus therapy is rapidly heating up ]